| scholarly article | Q13442814 |
| P2093 | author name string | D W Russell | |
| Y Li | |||
| J M Allen | |||
| Y Huo | |||
| L M Tuschong | |||
| T R Bauer | |||
| T H Burkholder | |||
| E M Olson | |||
| P2860 | cites work | Physiological promoters reduce the genotoxic risk of integrating gene vectors | Q40003414 |
| A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses | Q40022227 | ||
| Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. | Q40651725 | ||
| Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning | Q44044895 | ||
| Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors | Q45676086 | ||
| Transduction of umbilical cord blood CD34+ NOD/SCID-repopulating cells by simian foamy virus type 1 (SFV-1) vector | Q45730083 | ||
| Improved foamy virus vectors with minimal viral sequences | Q45730940 | ||
| Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors | Q45736388 | ||
| Versatile retroviral vectors for potential use in gene therapy | Q45867146 | ||
| Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiency | Q45871544 | ||
| Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector | Q45880148 | ||
| Cytokine transgene expression and promoter usage in primary CD34+ cells using particle-mediated gene delivery | Q45889748 | ||
| A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency | Q47923012 | ||
| Expression and function of adhesion molecules on human hematopoietic stem cells: CD34+ LFA-1- cells are more primitive than CD34+ LFA-1+ cells | Q67898013 | ||
| Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells | Q81353679 | ||
| Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha | Q24317250 | ||
| Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease | Q28143064 | ||
| LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 | Q28210584 | ||
| Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration | Q28242708 | ||
| Transcription start regions in the human genome are favored targets for MLV integration | Q29618456 | ||
| HIV-1 integration in the human genome favors active genes and local hotspots | Q29618457 | ||
| Foamy and lentiviral vectors transduce canine long-term repopulating cells at similar efficiency | Q33688423 | ||
| Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system | Q33888773 | ||
| Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors | Q34032399 | ||
| Foamy virus vector integration sites in normal human cells | Q34334976 | ||
| Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. | Q34508425 | ||
| Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy | Q35011497 | ||
| Foamy virus vectors. | Q35196137 | ||
| Replication of primate foamy viruses in natural and experimental hosts. | Q35196141 | ||
| Foamy-virus-mediated gene transfer to canine repopulating cells | Q35615750 | ||
| The mouse Pgk-1 gene promoter contains an upstream activator sequence | Q35788889 | ||
| Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity | Q35849232 | ||
| The genetic immunodeficiency disease, leukocyte adhesion deficiency, in humans, dogs, cattle, and mice. | Q35882651 | ||
| Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency | Q36290418 | ||
| Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors | Q36362910 | ||
| Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. | Q36424249 | ||
| Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients | Q36812729 | ||
| The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy | Q37143395 | ||
| Improved primate foamy virus vectors and packaging constructs | Q39683205 | ||
| P433 | issue | 6 | |
| P921 | main subject | vector-borne disease | Q2083837 |
| P304 | page(s) | 553-559 | |
| P577 | publication date | 2011-01-13 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter | |
| P478 | volume | 18 |
| Q93116167 | CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites |
| Q38110363 | Current progress on gene therapy for primary immunodeficiencies |
| Q38724310 | Evidence for the in vivo safety of insulated foamy viral vectors |
| Q38121801 | Feline foamy virus-based vectors: advantages of an authentic animal model |
| Q45326104 | Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential |
| Q56935361 | Foamy Virus Vectors Transduce Visceral Organs and Hippocampal Structures following In Vivo Delivery to Neonatal Mice |
| Q45068770 | Immunisation with foamy virus Bet fusion proteins as novel strategy for HIV-1 epitope delivery |
| Q30409845 | Intravenous injection of a foamy virus vector to correct canine SCID-X1. |
| Q36482767 | Large animal models for foamy virus vector gene therapy |
| Q36883869 | Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency. |
| Q35784865 | Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy |
| Q37898045 | The function of dog models in developing gene therapy strategies for human health |
| Q34295186 | Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis |
Search more.